In one paragraphArticle in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Natalia V PozdniakovaN.N. Blokhin National Medical Research Center of Oncology of the Ministry of Public Health of the Russian Federation (N.N. Blokhin NMRCO), Kashirskoe Shosse, 23, 115478 Moscow, Russia.ORCID 0000-0002-5765-3016 Alexey A LipengoltsN.N. Blokhin National Medical Research Center of Oncology of the Ministry of Public Health of the Russian Federation (N.N. Blokhin NMRCO), Kashirskoe Shosse, 23, 115478 Moscow, Russia.
Vsevolod A SkribitskyN.N. Blokhin National Medical Research Center of Oncology of the Ministry of Public Health of the Russian Federation (N.N. Blokhin NMRCO), Kashirskoe Shosse, 23, 115478 Moscow, Russia.ORCID 0000-0003-2942-7895 Kristina E ShpakovaN.N. Blokhin National Medical Research Center of Oncology of the Ministry of Public Health of the Russian Federation (N.N. Blokhin NMRCO), Kashirskoe Shosse, 23, 115478 Moscow, Russia.ORCID 0000-0003-0246-1794 Yulia A FinogenovaN.N. Blokhin National Medical Research Center of Oncology of the Ministry of Public Health of the Russian Federation (N.N. Blokhin NMRCO), Kashirskoe Shosse, 23, 115478 Moscow, Russia.ORCID 0000-0002-5144-1039 Anna V SmirnovaN.N. Blokhin National Medical Research Center of Oncology of the Ministry of Public Health of the Russian Federation (N.N. Blokhin NMRCO), Kashirskoe Shosse, 23, 115478 Moscow, Russia.
Alexei B ShevelevN.I. Vavilov Institute of General Genetics RAS, Gubkina Street, 3, GSP-1, 119991 Moscow, Russia.ORCID 0000-0003-3564-7405 Elena Y GrigorievaN.N. Blokhin National Medical Research Center of Oncology of the Ministry of Public Health of the Russian Federation (N.N. Blokhin NMRCO), Kashirskoe Shosse, 23, 115478 Moscow, Russia.
Funding
CSRD VA 1
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Mice, Inbred BALB CRecombinant ProteinsTechnetiumTomography, Emission-Computed, Single-PhotonAnimalsCell Line, TumorFemaleIntegrin alphaVbeta3Lung NeoplasmsMiceMice, Inbred C57BLNeoplasm TransplantationRadiopharmaceuticalsSingle Photon Emission Computed Tomography Computed TomographyTissue DistributionIntegrin alphaVbeta3RadiopharmaceuticalsRecombinant ProteinsTechnetiumcancerde novo protein designin vivo imagingSPECTtargeted deliverytechnetium
Identifiers
PMID39337680
PMCPMC11432708
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390